Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SPNC [NASD]
The Spectranetics Corporation
Index- P/E- EPS (ttm)-0.01 Insider Own0.50% Shs Outstand41.33M Perf Week4.39%
Market Cap1.00B Forward P/E654.86 EPS next Y0.04 Insider Trans6.16% Shs Float40.28M Perf Month-23.23%
Income-0.40M PEG- EPS next Q-0.14 Inst Own87.50% Short Float3.99% Perf Quarter-2.92%
Sales158.80M P/S6.31 EPS this Y-116.70% Inst Trans0.22% Short Ratio3.64 Perf Half Y29.30%
Book/sh4.62 P/B5.24 EPS next Y119.00% ROA-0.20% Target Price31.33 Perf Year28.34%
Cash/sh3.11 P/C7.80 EPS next 5Y8.35% ROE-0.20% 52W Range15.52 - 31.94 Perf YTD-3.08%
Dividend- P/FCF- EPS past 5Y39.20% ROI-0.20% 52W High-24.14% Beta1.08
Dividend %- Quick Ratio6.80 Sales past 5Y8.80% Gross Margin73.90% 52W Low56.12% ATR1.45
Employees575 Current Ratio7.20 Sales Q/Q13.90% Oper. Margin3.10% RSI (14)39.58 Volatility6.58% 5.62%
OptionableYes Debt/Eq0.00 EPS Q/Q0.00% Profit Margin-0.30% Rel Volume1.01 Prev Close23.08
ShortableYes LT Debt/Eq0.00 EarningsApr 23 AMC Payout- Avg Volume440.57K Price24.23
Recom1.80 SMA20-10.77% SMA50-13.28% SMA2009.02% Volume442,780 Change4.98%
08-Apr-14Reiterated Needham Buy $35 → $30
08-Apr-14Reiterated Canaccord Genuity Buy $35 → $30
21-Mar-14Initiated Needham Buy $35
25-Feb-14Reiterated Stifel Buy $24 → $30
03-Feb-14Downgrade Northland Capital Market Perform → Under Perform $20
26-Nov-13Initiated CRT Capital Buy $26.50
25-Jun-13Resumed Stifel Buy $24
20-May-13Downgrade Northland Capital Outperform → Market Perform
04-Feb-13Reiterated Northland Capital Outperform $16 → $20
07-Sep-12Initiated Northland Securities Outperform $16
25-Apr-12Reiterated Barrington Research Outperform $11 → $13
19-Mar-12Reiterated Canaccord Genuity Buy $12 → $14.50
29-Jul-10Reiterated Rodman & Renshaw Mkt Outperform $12 → $9
08-Jan-10Initiated Rodman & Renshaw Mkt Outperform $12
30-Dec-09Reiterated Canaccord Adams Buy $9 → $11
26-Oct-09Upgrade Stifel Nicolaus Hold → Buy $8
11-Sep-09Upgrade Canaccord Adams Hold → Buy $4 → $8
24-Jul-09Reiterated Caris & Company Average $4 → $6
24-Jul-09Downgrade Jefferies & Co Buy → Hold $5
20-Feb-09Reiterated Jefferies & Co Buy $7 → $4
16-Apr-14 04:07PM  SPECTRANETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
15-Apr-14 11:17AM  J&J Earnings Beat Estimates As Pharma Sales Shine at Investor's Business Daily
11-Apr-14 11:37AM  Commit To Buy Spectranetics At $20, Earn 9.6% Annualized Using Options at TheStreet
10-Apr-14 04:11PM  Spectranetics gets FDA clearance for mechanical lead extraction devices at theflyonthewall.com
04:05PM  Spectranetics Announces FDA Clearance for Mechanical Lead Extraction Devices GlobeNewswire
09-Apr-14 06:06PM  Nasdaq stocks posting largest percentage decreases AP
01:16PM  Nasdaq stocks posting largest percentage decreases AP
08-Apr-14 06:29PM  Nasdaq stocks posting largest percentage decreases AP -11.87%
02:05PM  Why Spectranetics (SPNC) Stock Is Plummeting Today at TheStreet
01:16PM  Nasdaq stocks posting largest percentage decreases AP
07:29AM  Spectranetics price target lowered to $30 from $35 at Canaccord at theflyonthewall.com
07-Apr-14 04:06PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online -6.38%
04:02PM  Spectranetics Announces Preliminary Results for First Quarter 2014 and Updates 2014 Guidance GlobeNewswire
04-Apr-14 12:46PM  Medical appliance stocks: Analyst shares her picks at CNBC
27-Mar-14 08:00AM  Spectranetics Announces Early Success of EXCITE ISR; Clinical Trial Demonstrated Safety and Efficacy Superiority GlobeNewswire
21-Mar-14 06:33AM  Coverage initiated on Spectranetics by Needham Briefing.com
17-Mar-14 11:54AM  Wall Street Transcript Interview with Gregory J. Fluet, the CEO of Urologix, Inc. (ULGX) Wall Street Transcript
06-Mar-14 01:04PM  SPECTRANETICS CORP Financials EDGAR Online Financials
28-Feb-14 01:02PM  SPECTRANETICS CORP Files SEC form 10-K, Annual Report EDGAR Online
02:34AM  The Spectranetics' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
02:34AM  The Spectranetics' CEO Discusses Q4 2013 Results - Earnings Call Transcript
27-Feb-14 04:30PM  Spectranetics Earnings Call scheduled for 4:30 pm ET today CCBN
04:08PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:05PM  Spectranetics Achieves Fourth Quarter Revenue of $41.9 Million GlobeNewswire
07:34AM  Spectranetics Earnings Call scheduled for 4:30 pm ET today CCBN
07:07AM  Q4 2013 Spectranetics Earnings Release - After Market Close CCBN
26-Feb-14 03:48PM  SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obl EDGAR Online
24-Feb-14 04:08PM  SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
04:05PM  Spectranetics Achieves Statistical Endpoints of EXCITE ISR Adjunct Analysis GlobeNewswire
10-Feb-14 04:05PM  Spectranetics to Hold 2013 Fourth Quarter Financial Results Conference Call on February 27 GlobeNewswire
03-Feb-14 07:34AM  Spectranetics downgraded by Northland Capital Briefing.com
15-Jan-14 10:27PM  The Spectranetics' CEO Presents at 32nd JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
10:27PM  The Spectranetics' CEO Presents at 32nd JPMorgan Healthcare Conference (Transcript)
06-Jan-14 04:05PM  Spectranetics to Present at the JP Morgan 32nd Annual Healthcare Conference GlobeNewswire
04:05PM  Spectranetics to Present at the JP Morgan 32nd Annual Healthcare Conference
29-Nov-13 07:40AM  Canaccord says to add to Spectranetics positions at theflyonthewall.com
07:40AM  Canaccord says to add to Spectranetics positions
26-Nov-13 08:27AM  Coverage initiated on Spectranetics by CRT Capital Briefing.com
08:27AM  Coverage initiated on Spectranetics by CRT Capital
19-Nov-13 04:05PM  Spectranetics to Present at the Piper Jaffray 25th Annual Healthcare Conference GlobeNewswire
04:05PM  Spectranetics to Present at the Piper Jaffray 25th Annual Healthcare Conference
06-Nov-13 01:04PM  SPECTRANETICS CORP Financials EDGAR Online Financials
01:04PM  SPECTRANETICS CORP Financials
31-Oct-13 04:12PM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
04:12PM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report
30-Oct-13 04:05PM  Spectranetics to Participate in Canaccord Genuity Medical Technology and Diagnostics Forum GlobeNewswire
04:05PM  Spectranetics to Participate in Canaccord Genuity Medical Technology and Diagnostics Forum
24-Oct-13 08:16PM  The Spectranetics' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
08:16PM  The Spectranetics' CEO Discusses Q3 2013 Results - Earnings Call Transcript
04:30PM  Spectranetics Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  The Spectranetics Corporation Discusses Q3 2013 Results (Webcast) at Seeking Alpha
04:25PM  The Spectranetics Corporation Discusses Q3 2013 Results (Webcast)
04:23PM  InPlay: Spectranetics reports EPS in-line, beats on revs; guides FY13 EPS in-line, revs in-line Briefing.com
04:07PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:07PM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
04:03PM  Spectranetics Achieves Third Quarter Revenue of $39.8 Million GlobeNewswire
07:07AM  Q3 2013 Spectranetics Earnings Release - After Market Close CCBN
16-Oct-13 05:40PM  [video] Health care companies bit the bullet up front: Pro at CNBC
09-Oct-13 04:00PM  Spectranetics to Hold 2013 Third Quarter Financial Results Conference Call on October 24 GlobeNewswire
16-Sep-13 08:00AM  Colorado-based Spectranetics and Paladina Health Announce Innovative Alliance Business Wire
11-Sep-13 06:17PM  The Spectranetics's CEO Presents at Morgan Stanley Healthcare Conference (Transcript) at Seeking Alpha
26-Aug-13 08:30AM  Spectranetics to Participate in Upcoming Investor Conferences GlobeNewswire
22-Aug-13 04:10PM  SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:05PM  Kimberly Bridges Named to Lead Vascular Intervention Business Unit at Spectranetics GlobeNewswire
19-Aug-13 04:05PM  Spectranetics Broadens Laser Catheter Portfolio to Treat Complex Lesions and Chronic Total Occlusions (CTOs) GlobeNewswire
14-Aug-13 06:19AM  Spectranetics initiated with an Overweight at JPMorgan theflyonthewall.com
09-Aug-13 09:31AM  SPECTRANETICS CORP Files SEC form 8-K, Other Events EDGAR Online
08-Aug-13 01:04PM  SPECTRANETICS CORP Financials EDGAR Online Financials
06-Aug-13 11:54AM  A Focus on Growth-Oriented Medical Device Names with Transcatheter Heart Valve and Insulin Pump Technologies: Raj Denhoy, Expert Analyst, Shares His Top Picks with The Wall Street Transcript Wall Street Transcript
01-Aug-13 08:07AM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
29-Jul-13 04:10PM  Spectranetics to Participate in Upcoming Conferences GlobeNewswire
28-Jul-13 03:52PM  These 5 Stocks Saw Trading Price Swings This Past Week Post Earnings at Wall St. Cheat Sheet
25-Jul-13 07:00AM  3 Stocks Rising on Unusual Volume at TheStreet
24-Jul-13 05:18PM  Spectranetics Has Multiple Attractive Opportunities, But Will They Execute? at Seeking Alpha
04:42PM  The Spectranetics Corporation (SPNC) CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
11:13AM  The Spectranetics Earnings: Heres Why Investors are Excited Now at Wall St. Cheat Sheet
11:00AM  Spectranetics Earnings Call scheduled for 11:00 am ET today CCBN
10:49AM  Spectranetics Earnings Call scheduled for 11:00 am ET today CCBN
07:34AM  Spectranetics Earnings Call scheduled for 11:00 am ET today CCBN
07:07AM  Q2 2013 Spectranetics Earnings Release - Before Market Open CCBN
06:15AM  InPlay: Spectranetics reports EPS in-line, beats on revs; reaffirms FY13 EPS guidance, raises FY13 revs in-line Briefing.com
06:00AM  Spectranetics Achieves Second Quarter Revenue of $39.5 Million GlobeNewswire
03:07AM  SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
23-Jul-13 08:46PM  The Spectranetics Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet
22-Jul-13 01:53AM  Will Spectranetics Beat These Analyst Estimates? at Motley Fool
11-Jul-13 04:10PM  Spectranetics to Hold 2013 Second Quarter Financial Results Conference Call on July 24 GlobeNewswire
09-Jul-13 11:43AM  Miss SPNC's $18 Secondary But Think It's A Deal At $17.50? at Forbes
05-Jul-13 01:10AM  Has Spectranetics Made You Any Fast Money? at Motley Fool
02-Jun-13 11:03PM  SPECTRANETICS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
23-May-13 05:03PM  1 Reason to Expect Big Things from Spectranetics at Motley Fool
20-May-13 12:20AM  Spectranetics downgraded by Northland Capital Briefing.com
15-May-13 01:04PM  SPECTRANETICS CORP Financials EDGAR Online Financials
09-May-13 07:00AM  SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
06-May-13 04:04PM  InPlay: Spectranetics announces FDA approval of its adjunct analysis plan associated with the EXCITE ISR clinical trial, studying the treatment of in-stent restenosis in the legs Briefing.com
04:01PM  Spectranetics Finalizes EXCITE ISR Adjunct Analysis Plan GlobeNewswire
01-May-13 04:06PM  Spectranetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Over-Allotment Option GlobeNewswire
09:38AM  Insiders Bullish on Certain Holdings of IWC at Forbes
26-Apr-13 02:53PM  4 Stocks Rising on Unusual Volume at TheStreet
03:58AM  SPECTRANETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online
25-Apr-13 07:00PM  Spectranetics Prices Public Offering of Common Stock GlobeNewswire +5.42%
The Spectranetics Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system. Its products are used to treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads. The company's vascular intervention product line includes peripheral atherectomy, a range of laser catheters for ablation of blockages in arteries above and below the knee; crossing solutions, which support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions; and coronary atherectomy and thrombectomy, which are aspiration and cardiac laser catheters for the treatment of blockages in the heart. Its primary vascular intervention products include the Turbo Elite and Turbo-Tandem laser catheters and the TAPAS drug delivery catheters for peripheral atherectomy; crossing catheters, such as the Quick-Cross, Quick-Cross Select, and Quick-Cross Extreme; the ELCA Laser Ablation Catheter for coronary atherectomy; and QuickCat aspiration catheter for thrombus management. The company's lead management product line comprises excimer laser sheaths, non-laser sheaths, and cardiac lead management accessories, such as Spectranetics Laser Sheath, GlideLight, and Lead Locking Device for the removal of pacemaker and defibrillator cardiac leads. It sells its products in the United States, Canada, Europe, the Middle East, the Asia Pacific, Latin America, and Puerto Rico. The Spectranetics Corporation was founded in 1984 and is headquartered in Colorado Springs, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Matin ShahriarChief Operating OfficerApr 15Option Exercise0.004,375031,072Apr 17 10:46 AM
Bowe Wade AVice President R&DApr 15Option Exercise0.002,500028,705Apr 17 10:45 AM
CHILDS GUY ACFOApr 15Option Exercise0.006,7000143,645Apr 17 10:46 AM
CHILDS GUY ACFOApr 03Option Exercise2.745,00013,700141,945Apr 03 06:08 PM
CHILDS GUY ACFOApr 03Sale29.215,000146,059136,945Apr 03 06:08 PM
CHILDS GUY ACFOMar 06Option Exercise2.745,00013,700141,945Mar 07 03:44 PM
CHILDS GUY ACFOMar 06Sale30.645,000153,189136,945Mar 07 03:44 PM
CHILDS GUY ACFOFeb 06Option Exercise2.745,00013,700143,945Feb 07 06:54 PM
CHILDS GUY ACFOFeb 06Sale24.905,000124,523138,945Feb 07 06:54 PM
Bowe Wade AVice President R&DFeb 03Option Exercise6.4614,17291,60736,543Feb 04 04:00 PM
Bowe Wade AVice President R&DFeb 03Sale25.1110,338259,56526,205Feb 04 04:00 PM
CHILDS GUY ACFOJan 02Option Exercise2.745,00013,700143,945Jan 02 06:08 PM
CHILDS GUY ACFOJan 02Sale24.905,000124,519138,945Jan 02 06:08 PM
CHILDS GUY ACFODec 05Option Exercise2.745,00013,700143,945Dec 05 06:22 PM
CHILDS GUY ACFODec 05Sale22.775,000113,860138,945Dec 05 06:22 PM
CHILDS GUY ACFONov 07Option Exercise2.745,00013,700143,945Nov 08 01:12 PM
CHILDS GUY ACFONov 07Sale20.235,000101,146138,945Nov 08 01:12 PM
Bowe Wade AVice President R&DNov 01Option Exercise6.4614,17291,52433,308Nov 04 03:40 PM
Bowe Wade AVice President R&DNov 01Sale20.7310,937226,71722,371Nov 04 03:40 PM
Bowe Wade AVice President R&DOct 25Sale19.372,05439,79519,136Oct 28 06:24 PM
Bowe Wade AVice President R&DAug 19Option Exercise4.0314,17257,11530,822Aug 20 06:42 PM
Dowling Anne MelissaDirectorAug 19Sale17.202,73547,04636,788Aug 20 06:42 PM
Bowe Wade AVice President R&DAug 19Sale17.209,632165,69021,190Aug 20 06:42 PM
Drake Scott WilliamPresident, CEOAug 10Option Exercise0.0012,500039,865Aug 12 06:47 PM
Hein Jason DSr. VP Commercial OperationsJul 01Option Exercise2.743,0008,22067,486Jul 03 07:46 PM
Hein Jason DSr. VP Commercial OperationsJul 01Sale18.953,00056,85064,486Jul 03 07:46 PM
Bowe Wade AVice President R&DJun 27Option Exercise2.821,2503,52516,650Jul 01 05:37 PM
Matin ShahriarSr VP of Ops, Bus. Dev., IntlJun 01Option Exercise0.002,500027,496Jun 04 07:33 PM
CHILDS GUY ACFOJun 01Option Exercise0.002,9250139,880Jun 04 07:33 PM
Wertheimer RogerVP, General Counsel, SecretaryJun 01Option Exercise0.003,750012,385Jun 04 07:33 PM
Bowe Wade AVice President R&DJun 01Option Exercise0.002,075016,063Jun 04 07:33 PM
Hein Jason DSr. VP Commercial OperationsJun 01Option Exercise0.002,500065,285Jun 04 07:33 PM